Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Profermin® to Induce Remission in Patients With Ulcerative Colitis

NCT01245465 is registered in ClinicalTrials.gov with Nordisk Rebalance A/S as lead sponsor.

NCT NCT01245465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01245465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Profermin® to Induce Remission in Patients With Ulcerative Colitis
Lead sponsor
Nordisk Rebalance A/S
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2009
Completion date
November 30, 2009
Enrollment
39 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis